Tillotts, part of the Japanese Zeria Group, is offering Octasa 1600 mg (mesalazine) delayed-release tablets as first-line treatment for moderately active ulcerative colitis in Canada. “Tillotts has a ...
Jeremy Thorpe, managing director of Tillotts Pharma tells us how his company has thrived in the UK GI-specialist Tillotts has seen some remarkable success in the past five years – following re-entry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results